Advertisement
UK markets close in 6 hours 47 minutes
  • FTSE 100

    8,083.33
    +38.52 (+0.48%)
     
  • FTSE 250

    19,799.72
    0.00 (0.00%)
     
  • AIM

    755.48
    +0.61 (+0.08%)
     
  • GBP/EUR

    1.1630
    +0.0002 (+0.02%)
     
  • GBP/USD

    1.2427
    -0.0025 (-0.20%)
     
  • Bitcoin GBP

    53,553.20
    +346.77 (+0.65%)
     
  • CMC Crypto 200

    1,435.43
    +11.33 (+0.80%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    83.05
    -0.31 (-0.37%)
     
  • GOLD FUTURES

    2,331.80
    -10.30 (-0.44%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,201.96
    +64.31 (+0.35%)
     
  • CAC 40

    8,121.09
    +15.31 (+0.19%)
     

Why Enochian BioSciences Was a Winner on Monday

Why Enochian BioSciences Was a Winner on Monday

Biotech Enochian BioSciences (NASDAQ: ENOB) enjoyed a nice share price lift on Monday. Enochian explained that this technique is effected through a nanoparticle, which gives scope for either rapid treatment of an infection, or an "ambush" in which it effectively waits in a cell for infection, then strikes. This technology was developed by the biotech's co-founder Serhat Gumrukcu.